RhumbLine Advisers’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.17M Sell
181,599
-6,617
-4% -$261K 0.01% 1221
2025
Q1
$5.68M Sell
188,216
-3,677
-2% -$111K 0.01% 1291
2024
Q4
$6.71M Sell
191,893
-5,049
-3% -$177K 0.01% 1266
2024
Q3
$7.89M Buy
196,942
+18,853
+11% +$755K 0.01% 1180
2024
Q2
$8.49M Sell
178,089
-1,330
-0.7% -$63.4K 0.01% 1110
2024
Q1
$7.78M Sell
179,419
-19,997
-10% -$867K 0.01% 1173
2023
Q4
$10.1M Buy
199,416
+1,956
+1% +$99K 0.01% 1054
2023
Q3
$8.96M Buy
197,460
+127
+0.1% +$5.76K 0.01% 1038
2023
Q2
$8.1M Buy
197,333
+20,648
+12% +$847K 0.01% 1119
2023
Q1
$6.32M Buy
176,685
+11,522
+7% +$412K 0.01% 1187
2022
Q4
$6.24M Buy
165,163
+9,449
+6% +$357K 0.01% 1158
2022
Q3
$6.89M Buy
155,714
+1,212
+0.8% +$53.6K 0.01% 1080
2022
Q2
$5.72M Buy
154,502
+20,942
+16% +$775K 0.01% 1176
2022
Q1
$4.95M Sell
133,560
-6,189
-4% -$229K 0.01% 1318
2021
Q4
$4.25M Buy
139,749
+1,386
+1% +$42.2K 0.01% 1451
2021
Q3
$4.64M Sell
138,363
-1,222
-0.9% -$41K 0.01% 1402
2021
Q2
$5.57M Sell
139,585
-4,821
-3% -$192K 0.01% 1368
2021
Q1
$6.49M Sell
144,406
-7,405
-5% -$333K 0.01% 1255
2020
Q4
$8.58M Sell
151,811
-2,634
-2% -$149K 0.01% 1024
2020
Q3
$7.33M Sell
154,445
-5,360
-3% -$254K 0.01% 933
2020
Q2
$9.42M Buy
159,805
+20,354
+15% +$1.2M 0.02% 805
2020
Q1
$6.59M Sell
139,451
-1,833
-1% -$86.7K 0.01% 868
2019
Q4
$8.54M Buy
141,284
+3,423
+2% +$207K 0.01% 933
2019
Q3
$8.26M Sell
137,861
-822
-0.6% -$49.2K 0.02% 888
2019
Q2
$8.91M Sell
138,683
-2,300
-2% -$148K 0.02% 839
2019
Q1
$11.4M Sell
140,983
-793
-0.6% -$64.4K 0.02% 700
2018
Q4
$7.66M Sell
141,776
-5,337
-4% -$289K 0.02% 853
2018
Q3
$7.59M Sell
147,113
-2,733
-2% -$141K 0.01% 832
2018
Q2
$6.24M Buy
149,846
+2,512
+2% +$105K 0.01% 952
2018
Q1
$6.49M Sell
147,334
-4,441
-3% -$196K 0.01% 884
2017
Q4
$7.63M Sell
151,775
-2,325
-2% -$117K 0.02% 823
2017
Q3
$7.81M Sell
154,100
-3,984
-3% -$202K 0.02% 790
2017
Q2
$8.04M Sell
158,084
-2,114
-1% -$108K 0.02% 736
2017
Q1
$6.44M Buy
160,198
+5,738
+4% +$231K 0.02% 861
2016
Q4
$7.39M Buy
154,460
+11,319
+8% +$541K 0.02% 759
2016
Q3
$5.25M Buy
143,141
+6,594
+5% +$242K 0.01% 856
2016
Q2
$3.18M Buy
136,547
+5,504
+4% +$128K 0.01% 1068
2016
Q1
$5.31M Buy
131,043
+90
+0.1% +$3.65K 0.02% 808
2015
Q4
$8.11M Buy
130,953
+2,370
+2% +$147K 0.03% 597
2015
Q3
$5.2M Buy
128,583
+2,778
+2% +$112K 0.02% 790
2015
Q2
$7.24M Sell
125,805
-4,956
-4% -$285K 0.02% 658
2015
Q1
$8.33M Buy
130,761
+19,050
+17% +$1.21M 0.02% 592
2014
Q4
$6.9M Sell
111,711
-3,237
-3% -$200K 0.02% 643
2014
Q3
$4.46M Sell
114,948
-1,925
-2% -$74.7K 0.01% 831
2014
Q2
$4.03M Sell
116,873
-2,722
-2% -$93.8K 0.01% 911
2014
Q1
$5.17M Sell
119,595
-4,960
-4% -$214K 0.02% 802
2013
Q4
$4.96M Buy
124,555
+6,190
+5% +$247K 0.01% 823
2013
Q3
$4.44M Sell
118,365
-403
-0.3% -$15.1K 0.01% 864
2013
Q2
$3.19M Buy
+118,768
New +$3.19M 0.01% 1021